This article was originally published on TipRanks.com Shares of Vertex Pharmaceuticals Incorporated (VRTX) jumped 9.
Summer’s going fast, and it’s time to consider one of the stock market’s peculiarities: we’re apt to see a bump in the fall, …
The board of Boston-based biopharmaceutical company Vertex Pharmaceuticals (VRTX) has approved a $1.5 billion share repurchase program, per the company’s SEC filing.
Shares in Vertex Pharmaceuticals plunged 12% in Wednesday’s extended market session after the pharma company announced the decision to stop the development of …
The COVID-19 pandemic had a mixed impact on pharma companies so far. During nationwide lockdowns, some companies benefited from the stockpiling of certain …
Moderna (MRNA) stock is up 2.7% in Thursday’s pre-market trading after the company inked a deal with Vertex Pharmaceuticals for the treatment of …
The old adage of ‘buy low, sell high’ is an oft-repeated mantra in investing circles, and it makes sense, too. There are other …
Vertex (VRTX) is Cowen analyst’s top large-cap pick for the second year in a row. That’s how Phil Nadeau put it while increasing …
Biopharmaceutical Vertex’ (VRTX) is working on a trial called Phase III VX-659 and Cowen analyst Phil Nadeau calls some recently released data “Good …
By Genia Turanova There’s nothing like cash to show how successful a company has been. When a fledgling enterprise first turns cash-flow positive …
